TY - JOUR
AB - Rogers et al.  Circulating Estradiol and OPG J Clin Endocrinol Metab, October 2002, 87(10):4470 – 4475 4475 1997 Isolation of a novel cytokine from human fibroblasts that specifically inhibits The effect of a single dose of osteoprotegerin in postmenopausal women. osteoclastogenesis. Biochem Biophys Res Commun 234:137–142 J Bone Miner Res 16:348 –360 10. Mizuno A, Amizuka N, Irie K, Murakami A, Fujise N, Kanno T, Sato Y, 16. Cooper C, O’Neill T, Silman A 1993 The epidemiology of vertebral fractures. Nakagawa N, Yasuda H, Mochizuki S, Gomibuchi T, Yano K, Shima N, European vertebral osteoporosis study group. Bone 14(Suppl 1):S89 –S97 Washida N, Tsuda E, Morinaga T, Higashio K, Ozawa H 1998 Severe osteo- 17. Hannon R, Blumsohn A, Naylor K, Eastell R 1998 Response of biochemical porosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. markers of bone turnover to hormone replacement therapy: impact of bio- Biochem Biophys Res Commun 247:610 – 615 logical variability. J Bone Miner Res 13:1124 –1133 11. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, 18. Browner WS, Lui LY, Cummings SR 2001 Associations of serum osteopro- Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio 
TI - CALL FOR NOMINATIONS, FASEB EXCELLENCE IN SCIENCE LECTURE AND AWARD 2004
JF - The Journal of Clinical Endocrinology & Metabolism
DO - 10.1210/jcem.87.10.9998
DA - 2002-10-01
UR - https://www.deepdyve.com/lp/oxford-university-press/call-for-nominations-faseb-excellence-in-science-lecture-and-award-uFFd2wePWr
SP - 4475
EP - 4475
VL - 87
IS - 10
DP - DeepDyve
ER -